Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€8.11
30.05.23
-
30.05.24
6.26%
12.06.23

Could be very worthwhile Investment >20% year
Capable Management
High valuation
Increased challenges to pay loans and raise capital
Sievi 
30.05.23 100%
sell
Verastem Inc.

Start price
Target price
Perf. (%)
€13.94
30.05.23
-
30.05.24
-19.06%
11.06.23

Could be very worthwhile Investment >20% year
blaugold 
30.05.23 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€1.30
31.05.23
-
31.05.24
-23.04%
11.06.23

blaugold 
31.05.23 50%
buy
Tempest Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.24
08.06.23
-
08.06.24
-12.10%
11.06.23

Could be worthwhile Investment >10% per year
blaugold 
08.06.23 50%
buy
Martin Midstream Partners L.P.

Start price
Target price
Perf. (%)
€1.02
13.04.22
€1.50
-
30.05.23

Could be worthwhile Investment >10% per year
melinda 
13.04.22 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€23.90
09.08.22
€35.00
09.08.23
-67.34%
30.05.23

edgaaar 
09.08.22 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.79
15.05.23
-
15.05.24
-1.17%
29.05.23

Could be very worthwhile Investment >20% year
blaugold 
15.05.23 50%
sell
Akoustis Technologies Inc

Start price
Target price
Perf. (%)
€2.58
26.04.23
€2.40
26.04.24
6.98%
28.05.23

Higher EBIT margin than peer group
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
26.04.23 60%
buy
Kulicke & Soffa Industries Inc.

Start price
Target price
Perf. (%)
€42.29
06.01.23
€54.00
06.01.24
13.27%
25.05.23

Could be very worthwhile Investment >20% year
Undervalued
Capable Management
Significant cyclical dependencies
Covacoro 
06.01.23 70%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.75
22.05.22
-
22.05.23
-78.27%
22.05.23

Lector 
22.05.22 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€3.19
11.06.22
€1.60
11.06.23
84.40%
19.05.23

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
11.06.22 50%
sell
Veru Inc

Start price
Target price
Perf. (%)
€14.79
07.06.22
-
07.06.23
-92.84%
19.05.23

Risky Investment
Global_Player 
07.06.22 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€14.42
29.08.22
-
29.08.23
-59.22%
19.05.23

Could be very worthwhile Investment >20% year
Global_Player 
29.08.22 50%
buy
American Public Ed.

Start price
Target price
Perf. (%)
€13.40
18.05.22
€18.00
18.05.23
-57.09%
19.05.23

Could be worthwhile Investment >10% per year
Good culture
tbackenh 
18.05.22 50%
buy
Stratasys Inc.

Start price
Target price
Perf. (%)
€14.00
16.05.23
€21.00
16.06.23
5.57%
18.05.23

Mori8 
16.05.23 50%
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.15
26.12.22
-
26.12.23
200.63%
18.05.23

Could be very worthwhile Investment >20% year
Wolf_of_WS 
26.12.22 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.84
17.10.22
-
17.10.23
40.63%
18.05.23

Risky Investment
quelbe60 
17.10.22 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.16
20.03.23
-
20.03.24
19.03%
18.05.23

quelbe60 
20.03.23 50%
buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€13.04
23.01.23
-
23.01.24
-3.72%
15.05.23

Risky Investment
Global_Player 
23.01.23 50%
buy
Pulmatrix Inc.

Start price
Target price
Perf. (%)
€2.76
03.05.23
-
03.05.24
-9.60%
15.05.23

Could be very worthwhile Investment >20% year
Global_Player 
03.05.23 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.12
10.05.23
-
10.05.24
9.93%
15.05.23

Risky Investment
Wolf_of_WS 
10.05.23 50%
sell
Overstock.com

Start price
Target price
Perf. (%)
€28.80
14.05.22
-
14.05.23
-37.21%
15.05.23

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
FXX 
14.05.22 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€2.01
08.05.23
-
08.05.24
-36.06%
14.05.23

Vassago1 
08.05.23 50%
buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.33
12.05.23
-
12.05.24
-2.26%
14.05.23

Risky Investment
Vassago1 
12.05.23 50%
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€8.16
01.05.23
€11.00
01.05.24
6.50%
13.05.23

Fair valuation
High dividend yield expected
Small Risks for its business
Little Investments for future growth
ReynadJ 
01.05.23 60%